Baricitinib
CAS number: 1187594-09-7
Baricitinib is a drug for the treatment of rheumatoid arthritis.
Our Controlled Substance and API portfolio is supported by a global network of GMP facilities: West Deptford, NJ; Devens, MA; North Andover, MA; Edinburgh, UK and Annan, UK.
Formula:
C16H17N7O2S
Molecular weight:
371.419 g/mol
Therapeutic area:
Treatment of rheumatoid arthritis
Monographs:
Please contact your Account Manager
Regulatory filings:
USDMF
Manufactured in:
Please contact your Account Manager
* Monographs are available on request
† Regulatory filings are available on request
Get in touch
Send us a message to request a quote or ask our advice. We'd be happy to hear from you.
